Search

everythinglearnresearchcommunity

for

Search:↓

Androgens can cause acne, excess hair, and hair loss, treatable with dermatologist-guided therapies.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

Various surgical techniques effectively treat skin diseases and cosmetic issues.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.